Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis in Adolescents and Children

Stopped Study population was insufficiently symptomatic to enable evaluation of the efficacy of the treatment. No safety concern.

Conditions

• Allergic Rhinitis Due to Dust Mite

Interventions

• DRUG: 300 IR house dust mites allergen extract tablet
• DRUG: Placebo tablet

Sponsor

Stallergenes Greer